Exploration of endoscopic findings and risk factors of early gastric cancer after eradication of Helicobacter pylori

References

• Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.
   PubMed Web of Science ®Google Scholar
• Schistosomes, liver flukes and Helicobacter pylori. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Lyon, 7–14 June 1994. IARC Monogr Eval Carcinog Risks Hum. 1994;61:1–241.
   PubMedGoogle Scholar
• Fukase K, Kato M, Kikuchi S, et al. Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial. Lancet (London, England). 2008;372(9636):392–397.
   PubMed Web of Science ®Google Scholar
• Plummer M, Franceschi S, Vignat J, et al. Global burden of gastric cancer attributable to Helicobacter pylori. Int J Cancer. 2015;136(2):487–490.
   PubMed Web of Science ®Google Scholar
• Fuccio L, Zagari RM, Eusebi LH, et al. Meta-analysis: can Helicobacter pylori eradication treatment reduce the risk for gastric cancer? Ann Intern Med. 2009;151(2):121–128.
   PubMed Web of Science ®Google Scholar
• Sugano K, Tack J, Kuipers EJ, et al. Kyoto global consensus report on Helicobacter pylori gastritis. Gut. 2015;64(9):1353–1367.
   PubMed Web of Science ®Google Scholar
• Ito M, Tanaka S, Takata S, et al. Morphological changes in human gastric tumours after eradication therapy of Helicobacter pylori in a short-term follow-up. Aliment Pharmacol Ther. 2005;21(5):559–566.
   PubMed Web of Science ®Google Scholar
• Saka A, Yagi K, Nimura S. Endoscopic and histological features of gastric cancers after successful Helicobacter pylori eradication therapy. Gastric Cancer. 2016;19(2):524–530.
   PubMed Web of Science ®Google Scholar
• Yamamoto K, Kato M, Takahashi M, et al. Clinicopathological analysis of early-stage gastric cancers detected after successful eradication of Helicobacter pylori. Helicobacter. 2011;16(3):210–216.
   PubMed Web of Science ®Google Scholar
• Shichijo S, Hirata Y. Characteristics and predictors of gastric cancer after Helicobacter pylori eradication. World J Gastroenterol. 2018;24(20):2163–2172.
   PubMed Web of Science ®Google Scholar
• Sakaki N, Iida Y, Okazaki Y, et al. Magnifying endoscopic observation of the gastric mucosa, particularly in patients with atrophic gastritis. Endoscopy. 1978;10(4):269–274.
   PubMed Web of Science ®Google Scholar
• Yagi K. Gastric cancer after H. pylori eradication therapy develops in the intermediate zone. Relationship to spasmolytic polypeptide-expressing metaplasia. Open Access J Surg. 2018;9(1):555751.
   Google Scholar
• Kazuyoshi Y. The differences of endoscopic features between chronic active gastritis and chronic inactive gastritis. In: Gong J, translation. Endoscopic diagnosis of gastric cancer detected after eradication of H. pylori. Liaoning: Liaoning Science and Technology Publishing House; 2017.
   Google Scholar
• Majima A, Dohi O, Takayama S, et al. Linked color imaging identifies important risk factors associated with gastric cancer after successful eradication of Helicobacter pylori. Gastrointest Endosc. 2019;90(5):763–769.
   PubMed Web of Science ®Google Scholar
• Sekikawa A, Fukui H, Sada R, et al. Gastric atrophy and xanthelasma are markers for predicting the development of early gastric cancer. J Gastroenterol. 2016;51(1):35–42.
   PubMed Web of Science ®Google Scholar
• Moribata K, Iguchi JK, Nakachi K, et al. Endoscopic features associated with development of metachronous gastric cancer in patients who underwent endoscopic resection followed by Helicobacter pylori eradication. Dig Endosc. 2016;28(4):434–442.
   PubMed Web of Science ®Google Scholar
• Nawata Y, Yagi K, Tanaka M, et al. Reversal phenomenon on the mucosal borderline relates to development of gastric cancer after successful eradication of H. pylori. J Gastroenterol Hepatol Res. 2017;6(2):2333–2338.
   Google Scholar
• Yao K. The endoscopic diagnosis of early gastric cancer. Ann Gastroenterol. 2013;26(1):11–22.
   PubMedGoogle Scholar
• Dixon MF. Gastrointestinal epithelial neoplasia: Vienna revisited. Gut. 2002;51(1):130–131.
   PubMed Web of Science ®Google Scholar
• Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma: 3rd English edition. Gastric Cancer. 2011;14(2):101–112.
   PubMed Web of Science ®Google Scholar
• Kimura K, Takemoto T. An endoscopic recognition of the atrophic border and its significance in chronic gastritis. Endoscopy. 1969;1(3):87–97.
   Google Scholar
• Nagata N, Shimbo T, Akiyama J, et al. Predictability of gastric intestinal metaplasia by mottled patchy erythema seen on endoscopy. Gastroenterol Res. 2011;4(5):203–209.
   PubMedGoogle Scholar
• Yagi K, Nakamura A, Sekine A. Characteristic endoscopic and magnified endoscopic findings in the normal stomach without Helicobacter pylori infection. J Gastroenterol Hepatol. 2002;17(1):39–45.
   PubMed Web of Science ®Google Scholar
• Endoscopic Classification Review Group. Update on the Paris classification of superficial neoplastic lesions in the digestive tract. Endoscopy. 2005;37(6):570–578.
   PubMed Web of Science ®Google Scholar
• Maeda M, Yamashita S, Shimazu T, et al. Novel epigenetic markers for gastric cancer risk stratification in individuals after Helicobacter pylori eradication. Gastric Cancer. 2018;21(5):745–755.
   PubMed Web of Science ®Google Scholar
• Shichijo S, Hirata Y, Niikura R, et al. Histologic intestinal metaplasia and endoscopic atrophy are predictors of gastric cancer development after Helicobacter pylori eradication. Gastrointest Endosc. 2016;84(4):618–624.
   PubMed Web of Science ®Google Scholar
• Yagi K, Honda H, Yang JM, et al. Magnifying endoscopy in gastritis of the corpus. Endoscopy. 2005;37(7):660–666.
   PubMed Web of Science ®Google Scholar
• Nomura S, Ida K, Terao S, et al. Endoscopic diagnosis of gastric mucosal atrophy: multicenter prospective study. Dig Endosc. 2014;26(6):709–719.
   PubMed Web of Science ®Google Scholar
• Kodama M, Murakami K, Okimoto T, et al. Ten-year prospective follow-up of histological changes at five points on the gastric mucosa as recommended by the updated Sydney system after Helicobacter pylori eradication. J Gastroenterol. 2012;47(4):394–403.
   PubMed Web of Science ®Google Scholar
• Kitamura S, Muguruma N, Okamoto K, et al. Clinicopathological assessment of gastric xanthoma as potential predictive marker of gastric cancer. Digestion. 2017;96(4):199–206.
   PubMed Web of Science ®Google Scholar
• Sekikawa A, Fukui H, Maruo T, et al. Gastric xanthelasma may be a warning sign for the presence of early gastric cancer. J Gastroenterol Hepatol. 2014;29(5):951–956.
   PubMed Web of Science ®Google Scholar
• Kaiserling E, Heinle H, Itabe H, et al. Lipid islands in human gastric mucosa: morphological and immunohistochemical findings. Gastroenterology. 1996;110(2):369–374.
   PubMed Web of Science ®Google Scholar
• Farinati F, Cardin R, Degan P, et al. Oxidative DNA damage accumulation in gastric carcinogenesis. Gut. 1998;42(3):351–356.
   PubMed Web of Science ®Google Scholar
• Kountouras J, Chatzopoulos D, Zavos C. Reactive oxygen metabolites and upper gastrointestinal diseases. Hepatogastroenterology. 2001;48(39):743–751.
   PubMedGoogle Scholar